Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of abciximab readministration in coronary intervention.
Madan M, Kereiakes DJ, Hermiller JB, Rund MM, Tudor G, Anderson L, McDonald MB, Berkowitz SD, Sketch MH Jr, Phillips HR 3rd, Tcheng JE. Madan M, et al. Among authors: tcheng je. Am J Cardiol. 2000 Feb 15;85(4):435-40. doi: 10.1016/s0002-9149(99)00768-7. Am J Cardiol. 2000. PMID: 10728946 Clinical Trial.
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
Kandzari DE, Tcheng JE, Cohen DJ, Bakhai A, Grines CL, Cox DA, Effron M, Stuckey T, Griffin JJ, Turco M, Carroll JD, Fahy M, Mehran R, Stone GW; CADILLAC Investigators. Kandzari DE, et al. Among authors: tcheng je. Am J Cardiol. 2003 Oct 1;92(7):779-84. doi: 10.1016/s0002-9149(03)00882-8. Am J Cardiol. 2003. PMID: 14516875 Clinical Trial.
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O'Neill WW, Lansky AJ, Griffin JJ; CADILLAC Investigators. Cox DA, et al. Among authors: tcheng je. Am J Cardiol. 2006 Aug 1;98(3):331-7. doi: 10.1016/j.amjcard.2006.01.102. Epub 2006 Jun 9. Am J Cardiol. 2006. PMID: 16860018 Clinical Trial.
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Thel MC, Califf RM, Tardiff BE, Gardner LH, Sigmon KN, Lincoff AM, Topol EJ, Kitt MM, Blankenship JC, Tcheng JE. Thel MC, et al. Among authors: tcheng je. Am J Cardiol. 2000 Feb 15;85(4):427-34. doi: 10.1016/s0002-9149(99)00767-5. Am J Cardiol. 2000. PMID: 10728945 Clinical Trial.
Final results of the ReoPro readministration registry.
Dery JP, Braden GA, Lincoff AM, Kereiakes DJ, Browne K, Little T, George BS, Sane DC, Cines DB, Effron MB, Mascelli MA, Langrall MA, Damaraju L, Barnathan ES, Tcheng JE; ReoPro Readministration Registry Investigators. Dery JP, et al. Among authors: tcheng je. Am J Cardiol. 2004 Apr 15;93(8):979-84. doi: 10.1016/j.amjcard.2003.12.051. Am J Cardiol. 2004. PMID: 15081439
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G, Aymong ED, Mehran R, Tcheng JE, Grines CL, Cox DA, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Lansky AJ, Stone GW; CADILLAC Investigators. Dangas G, et al. Among authors: tcheng je. Am J Cardiol. 2004 Oct 15;94(8):983-8. doi: 10.1016/j.amjcard.2004.06.050. Am J Cardiol. 2004. PMID: 15476608 Clinical Trial.
292 results